GlassScriptPhysician profile
Jamie Messer
NPI 1316926298
$1,399.77
in general payments reported to CMS, 2019-2025
33 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $298 · 2021: $137 · 2022: $91.28 · 2023: $160 · 2024: $83.96 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $95.71 | 2019-2020 | |
| Coloplast Corp | $88.45 | 2019-2023 | Speedicath |
| Eisai INC. | $73.54 | 2019-2021 | |
| Astellas Pharma US INC | $72.52 | 2019-2023 | Myrbetriq |
| Rochester Medical Corporation | $72.33 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $67.07 | 2023-2024 | Orgovyx, Gemtesa |
| Seagen INC. | $65.65 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $64.53 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $57.88 | 2023-2025 | Pylarify |
| Boston Scientific Corporation | $55.95 | 2025 | General - Therapies |
| Pfizer INC. | $47.41 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $47.24 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $46.35 | 2022-2023 | Yonsa |
| Blue Earth Diagnostics | $46.08 | 2020-2021 | |
| Urogen Pharma, INC. | $40.55 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $39.97 | 2019 | |
| Abbvie INC. | $39.89 | 2023-2024 | |
| Incyte Corporation | $36.27 | 2019-2020 | |
| Foundation Medicine, INC. | $34.41 | 2019-2020 | |
| Intuitive Surgical, INC. | $32.42 | 2025 | |
| Medtronic, INC. | $32.29 | 2025 | Interstim |
| Karl Storz Endoscopy-America | $30.64 | 2021 | |
| Procept Biorobotics Corporation | $30.43 | 2023 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $27.63 | 2019 | |
| Clinigen, INC. | $21.53 | 2020 | |
| Endo USA, INC. | $20.17 | 2024 | Xiaflex |
| Janssen Biotech, INC. | $19.78 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.88 | 2020 | |
| Cook Medical LLC | $17.53 | 2024 | Resonance |
| Medtronic USA, INC. | $17.19 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $15.30 | 2019 | |
| Rigel Pharmaceuticals, INC. | $14.56 | 2019 | |
| Clovis Oncology, INC. | $10.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Messer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.